FULLERTON, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announced today Scott T. Garrett, president and chief executive officer, and James T. Glover, senior vice president and chief financial officer, will host a conference call on Wednesday, November 2, 2005 at 8:30 a.m. ET to discuss the company’s third quarter results. Earnings will be released earlier that morning.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )
As previously announced on July 22, 2005, the company’s two-division structure has been integrated into a “one-company” organization. As a result the company will begin reporting revenues in the following four product areas:
* Chemistry Systems * Immunoassay Systems * Cellular Systems * Discovery and Automation Systems
Attached is historical quarterly sales data in this new format, as well as the new geographical classification of U.S. and International for 2004 and the first two quarters of 2005.
Conference Call Information
The call may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation 1044540. There will also be a live webcast of the call. It will be accessible to all investors through Beckman Coulter’s website at www.beckmancoulter.com or at www.streetevents.com. When accessing the webcast through the Beckman Coulter site, select “go to IR” under Investor Relations and find the call listed under “What’s Ahead.” The webcast will be archived on both websites for future on-demand replay.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of- care testing -- Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2004 annual sales of $2.4 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com
Contact: Jeanie Herbert (714) 773-7620 Director, Investor Relations Beckman Coulter, Inc. Key Product Sales - Reported Growth 2005 vs. 2004 2004 (Amounts in Millions) Qtr 1 Qtr 2 $ % $ % Product Line Clinical Chemistry Systems 159.8 11.2% 178.7 5.9% Cellular Systems 185.7 17.0% 190.3 2.9% Immunoassay Systems 79.3 25.6% 90.9 25.3% Disc, AutoSys, Nucleic Acid 111.9 10.1% 137.4 9.5% All Products 536.8 14.9% 597.4 8.3% Geography United States 307.7 11.9% 325.5 5.9% International 229.1 19.2% 271.9 11.2% Worldwide 536.8 14.9% 597.4 8.3% 2004 (Amounts in Millions) Qtr 3 Qtr 4 $ % $ % Product Line Clinical Chemistry Systems 173.6 12.3% 192.6 6.8% Cellular Systems 189.8 2.7% 225.5 4.3% Immunoassay Systems 96.8 31.6% 107.3 27.4% Disc, AutoSys, Nucleic Acid 120.9 -0.7% 167.6 6.1% All Products 581.2 8.7% 693.0 8.5% Geography United States 322.4 4.7% 378.1 10.5% International 258.8 14.0% 314.9 6.2% Worldwide 581.2 8.7% 693.0 8.5% 2005 (Amounts in Millions) Qtr 1 Qtr 2 $ % $ % Product Line Clinical Chemistry Systems 167.9 5.1% 175.7 -1.7% Cellular Systems 196.7 5.9% 206.4 8.4% Immunoassay Systems 97.5 22.9% 106.7 17.4% Disc, AutoSys, Nucleic Acid 114.0 1.8% 130.0 -5.4% All Products 576.1 7.3% 618.8 3.6% Geography United States 290.2 -5.7% 323.3 -0.7% International 285.9 24.8% 295.5 8.7% Worldwide 576.1 7.3% 618.8 3.6% Note: May not foot due to rounding. Clinical Chemistry Systems include: * Routine Chemistry * Protein and rapid test products (formerly part of Immunodiagnostics). Cellular Systems include: * Hematology * Coagulation (formerly part of Routine Chemistry) * Flow cytometry and related products (formerly part of Specialty Testing) Immunoassay Systems include: * All immunoassay products Discovery and Automation Systems include * All robotic automation and genetic analysis products * All centrifuge and analytical systems * Industrial particle characterization (formerly part of Specialty Testing) * Clinical diagnostic automation (formerly part of Routine Chemistry)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.
CONTACT: Jeanie Herbert, Director, Investor Relations, Beckman Coulter,Inc., +1-714-773-7620
Web site: http://www.beckmancoulter.com/
